Met Life Investment Management, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Met Life Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.99 - $17.73 $52,504 - $233,309	-13,159 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$11.19 - $16.92 $147,249 - $222,650	13,159 New	13,159 $222,000
Q2 2020 May 24, 2024	BUY	$4.42 - $12.66 $58,162 - $166,592	13,159 New	13,159 $148 Million
Q2 2020 Jun 26, 2023	BUY	$4.42 - $12.66 $58,162 - $166,592	13,159 New	13,159 $147,000
Q2 2020 Mar 22, 2023	BUY	$4.42 - $12.66 $58,162 - $166,592	13,159 New	13,159 $147,000
Q2 2020 Aug 14, 2020	BUY	$4.42 - $12.66 $58,162 - $166,592	13,159 New	13,159 $148,000

549K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $58M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.